Financial Report 5 OPERATING EXPENDITURES For the year ended 30 June 2024 $ For the year ended 30 June 2023 $ General and Administration Employee Expenditure - Staff wages and superannuation 1,404,370 1,320,309 - Directors’ fees 259,058 221,000 - Contractor fees – 1,920 - Other employment expenses 1,009,055 371,284 2,672,483 1,914,513 Administrative Costs - Professional and legal fees 612,005 2,147,043 - Legal settlement payment – 1,000,000 - Loss on deconsolidation of BARD1AG – 124,764 - Transfer to the income statement of FCTR component related to BARD1AG – 213,035 - ASX listing and transaction fees plus share registry fees 134,137 132,421 - Lease liability interest 40,766 59,524 - Other administration expenses 495,207 88,092 1,282,115 3,764,879 Depreciation and amortisation - Amortisation of acquired intangible asset - hTERT 54,933 54,790 - Amortisation of acquired intangible asset - Molecular Nets 892,581 890,144 - Amortisation of granted patents 28,385 20,030 - Depreciation of building improvements 24,168 24,102 - Depreciation of right-of-use assets – AASB 16 Leases 137,877 137,499 - Depreciation of plant and equipment 66,046 26,944 1,203,990 1,153,509 Per consolidated Statement of Comprehensive Income 5,158,586 6,832,901 45 Annual Report 2024
RkJQdWJsaXNoZXIy MjE2NDg3